These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20870158)

  • 1. Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity.
    Fujimura Y; Ito H; Takahashi H; Yasuno F; Ikoma Y; Zhang MR; Nanko S; Suzuki K; Suhara T
    Nucl Med Biol; 2010 Oct; 37(7):831-5. PubMed ID: 20870158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIC, an intracerebral beta(+)-range-sensitive probe for radiopharmacology investigations in small laboratory animals: binding studies with (11)C-raclopride.
    Zimmer L; Hassoun W; Pain F; Bonnefoi F; Lanièce P; Mastrippolito R; Pinot L; Pujol JF; Leviel V
    J Nucl Med; 2002 Feb; 43(2):227-33. PubMed ID: 11850489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man.
    Farde L; Hall H; Pauli S; Halldin C
    Synapse; 1995 Jul; 20(3):200-8. PubMed ID: 7570351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
    Thobois S; Vingerhoets F; Fraix V; Xie-Brustolin J; Mollion H; Costes N; Mertens P; Benabid AL; Pollak P; Broussolle E
    Arch Neurol; 2004 Nov; 61(11):1705-9. PubMed ID: 15534182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N; Wilson AA; Houle S; Kapur S
    Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
    Olsson H; Halldin C; Swahn CG; Farde L
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN; Kapur S; Seeman P; Wilson AA
    Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN; Kapur S; Reckless G; Wilson AA
    Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET.
    Hirvonen J; Hietala J; Kajander J; Markkula J; Rasi-Hakala H; Salminen JK; Någren K; Aalto S; Karlsson H
    J Psychopharmacol; 2011 Oct; 25(10):1329-36. PubMed ID: 20829308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
    Tóth M; Varrone A; Steiger C; Laszlovszky I; Horváth A; Kiss B; Gyertyán I; Adham N; Halldin C; Gulyás B
    Synapse; 2013 May; 67(5):258-64. PubMed ID: 23238770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
    Ito H; Okubo Y; Halldin C; Farde L
    Neuroimage; 1999 Feb; 9(2):235-42. PubMed ID: 9927552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons.
    Narendran R; Hwang DR; Slifstein M; Hwang Y; Huang Y; Ekelund J; Guillin O; Scher E; Martinez D; Laruelle M
    J Pharmacol Exp Ther; 2005 Oct; 315(1):80-90. PubMed ID: 16014571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.
    Willeit M; Ginovart N; Kapur S; Houle S; Hussey D; Seeman P; Wilson AA
    Biol Psychiatry; 2006 Mar; 59(5):389-94. PubMed ID: 16373068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in psychiatric brain imaging.
    Sedvall G; Farde L; Nybäck H; Pauli S; Persson A; Savic I; Wiesel FA
    Acta Radiol Suppl; 1990; 374():113-5. PubMed ID: 1966956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography inter-scanner differences in dopamine D₂ receptor binding measured with [¹¹C]FLB457.
    Kodaka F; Ito H; Shidahara M; Takano H; Takahashi H; Arakawa R; Nakayama K; Suhara T
    Ann Nucl Med; 2010 Nov; 24(9):671-7. PubMed ID: 20734246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of ([(11)C]carbonyl)raclopride and a comparison with ([(11)C]methyl)raclopride in a monkey PET study.
    Rahman O; Takano A; Amini N; Dahl K; Kanegawa N; Långström B; Farde L; Halldin C
    Nucl Med Biol; 2015 Nov; 42(11):893-8. PubMed ID: 26272268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of receptor density and affinity: comparison of the routine sequential method with a nonsequential method in studies of dopamine D2 receptors with [11C]raclopride.
    Doudet DJ; Jivan S; Holden JE
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):280-4. PubMed ID: 12621303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.